Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Colon Cancer treatment details. Chemotherapy. Seoul National University Bundang Hospital, Seoul, Korea



Survival: 9.2 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: Seoul National University Bundang Hospital
   
Journal: Link
   
Date: 9/2014

Description:
Patients:
This phase 2 study involved 41 metastatic colorectal cancer patients who had been previously treated with fluoropyrimidine, oxaliplatin and irinotecan. The median patient age was 62 years and 19 were male.

Treatment:
Patients received chemotherapy with gemcitabine and uracil–tegafur.

Toxicities:
The most severe toxicity was grade 4 thrombocytopenia. Grade 3 neutropenia and grade 2 skin rash and abdominal pain were also reported.

Results:
The median overall survival was 9.2 months.

Support:
This study was supported by Yuhan Corporation of Korea (makers of the study drugs).

Correspondence: Dr. Jee Hyun Kim; email: jhkimmd@snu.ac.kr

E-mail to a Friend Email Physician More Information